Qiagen N.V.

US$50.33As of Sun 8 Nov 2026, 12:00 UTC
NYSE:QGENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 7.64%
Div yield 5.48%
ROE 10.81%
Diagnostics & Research
Beta (5Y) 0.56
PE TTM 27.27
TSR TTM 8.22%
Mkt cap US$10.39B
ROIC 11.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$54
7.14%
(78.13%)
Hold 6|0|7|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.46
0.44
0.48
0.49
1.49%
1.72%
7.68%
6.28%
Revenue$M
660.2
645.1
632.2
617.5
7.24%
1.22%
(6.25%)
(6.25%)
Peers (US$10.39B)
Cap (US$)
PE
57.29B
32.08x
30.00B
27.91x
11.40B
53.14x
Capital
TTM
5Y
10Y
Leveragex
1.985
0.055
0.044
EBIT/Intx
14.65
0.263
0.327
Own earn%
102.32
(54.48)
(39.03)
Sh yield%
34.08
42.24
42.55
Owners
Insiders/Inst%
12.22
35.79
Short interest%
1.75
SBC / revenue%
1.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
8–11
$1 testx
−0.8
Incr. ROIC%
11